Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 129 of the 130 references it cites were found in a registry or an index.

Community-acquired bacterial meningitis.

Open access
van de Beek, Diederik, Brouwer, Matthijs C, Koedel, Uwe, Wall, Emma C·2021·The Lancet

Abstract

Progress has been made in the prevention and treatment of community-acquired bacterial meningitis during the past three decades but the burden of the disease remains high globally. Conjugate vaccines against the three most common causative pathogens (Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae) have reduced the incidence of disease, but with the replacement by non-vaccine pneumococcal serotypes and the emergence of bacterial strains with reduced susceptibility to antimicrobial treatment, meningitis continues to pose a major health challenge worldwide. In patients presenting with bacterial meningitis, typical clinical characteristics (such as the classic triad of neck stiffness, fever, and an altered mental status) might be absent and cerebrospinal fluid examination for biochemistry, microscopy, culture, and PCR to identify bacterial DNA are essential for the diagnosis. Multiplex PCR point-of-care panels in cerebrospinal fluid show promise in accelerating the diagnosis, but diagnostic accuracy studies to justify routine implementation are scarce and randomised, controlled studies are absent. Early administration of antimicrobial treatment (within 1 hour of presentation) improves outcomes and needs to be adjusted according to local emergence of drug resistance. Adjunctive dexamethasone treatment has proven efficacy beyond the neonatal age but only in patients from high-income countries. Further progress can be expected from implementing preventive measures, especially the development of new vaccines, implementation of hospital protocols aimed at early treatment, and new treatments targeting checkpoints of the inflammatory cascade.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(21)00883-7

Cites

129 of 130 references verified0 citation errors · 1 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 127 references

Cited by

See all 316

Metadata

Authors
van de Beek, D., Brouwer, M. C., Koedel, U., & Wall, E. C.
Affiliations
  • Amsterdam Neuroscience (NL)
  • Ludwig-Maximilians-Universität München (DE)
  • The Francis Crick Institute (GB)
Venue
The Lancet
Publisher
Elsevier BV
Published
2021-09
Volume
398
Issue
10306
Pages
1171-1183
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W3185221162
Cited by
292
References
127
Citations by year
2026: 59 · 2025: 92 · 2024: 54 · 2023: 53 · 2022: 31 · 2021: 1
FWCI
4.31
Type
journal article
Language
en
Open access
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
ZonMw
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords
community-acquired bacterial meningitis, Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae type b, conjugate vaccines, serotype replacement, antimicrobial resistance, cerebrospinal fluid PCR, point-of-care testing, multiplex PCR, disease burden, meningitis prevention
MeSH terms
Anti-Inflammatory Agents, Anti-Bacterial Agents, Dexamethasone, Humans, Neisseria meningitidis, Streptococcus pneumoniae, Polymerase Chain Reaction, Meningitis, Bacterial, Community-Acquired Infections, Haemophilus influenzae type b

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A second model labelled each claim on 2026-11-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Community-acquired bacterial meningitis. https://app.cochat.ai/papers/10.1016/s0140-6736(21)00883-7
The paper
van de Beek, D., Brouwer, M. C., Koedel, U., & Wall, E. C. (2021). Community-acquired bacterial meningitis. The Lancet. https://doi.org/10.1016/s0140-6736(21)00883-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.